Search Results 771-780 of 5806 for 力曼保養品好用嗎加:💗line:sammibaby💗瞭解更多👜感謝您對力曼的信任與支持！ 我們將秉持著一貫的品質和服務標準,為您帶來更多驚喜和滿意！👗连江县刮油最好的减肥方法🦆万华区韓國化妝品男士

1. An Extension Study to Assess the Safety of the Use of Cannabidiol in Children and Young Adults with Dravet or Lennox-Gastaut Syndromes - Mayo Clinic

   The purpose of this extension study is to investigate the safety of using cannabidiol in children and young adults with Dravet or Lennox-Gastaut syndromes that ...

2. Transgender and Gender Diverse Healthcare Screening Perceptions - Mayo Clinic

   The purpose of this study is to conduct interviews of Transgender and Gender Diverse (TGD) individuals to learn their perceptions of healthcare screenings.

3. A Study of SGN-BB228 to Treat Advanced Melanoma and Other Solid Tumors - Mayo Clinic

   The purpose of this study is to test the safety and side effects of a drug called SGN-BB228 in participants with melanoma and other solid tumors that are hard ...

4. A Study Assessing the Effectiveness and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women who have Advanced Breast Cancer which Progressed on or after Aromatase Inhibitor Treatment - Mayo Clinic

   ... line of endocrine therapy for metastatic disease; Newly diagnosed advanced breast cancer, then relapsed with documented evidence of progression after one ...

5. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

   JCAR017 is a CAR-T therapy directed against CD19 (a cell surface protein on NHL cancer cells), meaning that a patient's own T-cells are collected from their ...

6. Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b - Mayo Clinic

   About this study. The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab ...

8. A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/​r B-NHL) - Mayo Clinic

   The goal of this multicenter study is to test JNJ-90009530 in Relapsed or Refractory Non-Hodgkin Lymphoma Patients. The main questions the study aims to answer ...

9. A Study of How the Regulation of Resting Blood Pressure is Altered in Menopausal Women - Mayo Clinic

   About this study. The purpose of this study is to investigate whether the autonomic support of blood pressure alters after menopause in women, ...

10. Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) - Mayo Clinic

    The purpose of this study is to characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell ...